Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
PHG 
Koninklijke Philips NV ADR (PHG)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/09/2025: PHG (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $31.77
1 Year Target Price $31.77
| 1 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -4.43% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/09/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 22.35B USD | Price to earnings Ratio 77.68 | 1Y Target Price 31.77 |
Price to earnings Ratio 77.68 | 1Y Target Price 31.77 | ||
Volume (30-day avg) 3 | Beta 0.82 | 52 Weeks Range 20.72 - 31.75 | Updated Date 07/9/2025 |
52 Weeks Range 20.72 - 31.75 | Updated Date 07/9/2025 | ||
Dividends yield (FY) 4.03% | Basic EPS (TTM) 0.31 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.08% | Operating Margin (TTM) 3.78% |
Management Effectiveness
Return on Assets (TTM) 2.01% | Return on Equity (TTM) 1.99% |
Valuation
Trailing PE 77.68 | Forward PE 13.72 | Enterprise Value 29854822882 | Price to Sales(TTM) 1.24 |
Enterprise Value 29854822882 | Price to Sales(TTM) 1.24 | ||
Enterprise Value to Revenue 1.41 | Enterprise Value to EBITDA 9 | Shares Outstanding 925084032 | Shares Floating 755793628 |
Shares Outstanding 925084032 | Shares Floating 755793628 | ||
Percent Insiders - | Percent Institutions 6.5 |
Upturn AI SWOT
Koninklijke Philips NV ADR
Company Overview
History and Background
Koninklijke Philips NV ADR, founded in Eindhoven, Netherlands in 1891, initially focused on manufacturing light bulbs. It evolved into a diversified technology company with businesses in healthcare, consumer lifestyle, and lighting. In recent years, Philips has strategically shifted its focus toward healthcare technology.
Core Business Areas
- Diagnosis & Treatment: Develops and markets medical imaging systems (MRI, CT, X-ray), ultrasound, image-guided therapy, and related software and services. This is currently the core business segment.
- Connected Care: Offers patient monitoring solutions, telehealth services, and solutions for hospital workflow optimization. This segment is growing in importance.
- Personal Health: Includes consumer health products such as electric toothbrushes, shavers, and mother and child care products. This segment's significance has been reduced.
Leadership and Structure
The CEO of Philips is Roy Jakobs. The company operates with a management team overseeing its various business segments. Philips has a supervisory board responsible for overseeing the management board.
Top Products and Market Share
Key Offerings
- Magnetic Resonance Imaging (MRI) Systems: Philips is a leading provider of MRI systems used for diagnostic imaging. Competitors include GE Healthcare (GE), Siemens Healthineers (SIEGY), and Canon Medical Systems. Market share varies by region but is generally competitive with the top players. The market share is estimated between 20% and 25% based on regions and different models.
- Computed Tomography (CT) Systems: Philips offers a range of CT scanners used for medical imaging. Competitors include GE Healthcare (GE), Siemens Healthineers (SIEGY), and Canon Medical Systems. The market share is estimated between 15% and 20% based on regions and different models.
- Patient Monitoring Solutions: Provides devices and software for monitoring patients' vital signs in hospitals and other healthcare settings. Competitors include Masimo (MASI) and Medtronic (MDT).
- Sonicare Electric Toothbrushes: A leading brand of electric toothbrushes. Competitors include Procter & Gamble's Oral-B (PG) and Colgate-Palmolive (CL).
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing significant growth driven by aging populations, increasing prevalence of chronic diseases, and technological advancements. Demand for medical imaging, patient monitoring, and telehealth solutions is rising.
Positioning
Philips is positioned as a leading innovator in healthcare technology, with a focus on providing integrated solutions and services. Its competitive advantages include its strong brand reputation, global presence, and expertise in medical imaging and patient monitoring.
Total Addressable Market (TAM)
The global medical device market is projected to reach hundreds of billions of dollars, with specific segments such as medical imaging and patient monitoring representing substantial opportunities. Philips aims to capture a significant share of this TAM through innovation and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Global presence
- Innovation in healthcare technology
- Extensive portfolio of products and services
- Focus on integrated solutions
Weaknesses
- Complex organizational structure
- High restructuring costs
- Exposure to regulatory risks in healthcare
- Dependence on healthcare spending trends
- Past quality control issues related to sleep apnea devices
Opportunities
- Growth in emerging markets
- Increasing demand for telehealth solutions
- Advancements in artificial intelligence and machine learning
- Strategic partnerships with healthcare providers
- Expansion into new healthcare segments
Threats
- Intense competition from established players
- Pricing pressures in the healthcare industry
- Changing regulatory landscape
- Economic downturns
- Product liability claims
Competitors and Market Share
Key Competitors
- GE
- SIEGY
- MDT
- MASI
Competitive Landscape
Philips benefits from a strong brand, global reach, and technological innovation. However, it faces challenges related to costs, regulation, and competition from larger, more diversified companies. Recent recalls have also negatively impacted its competitive positioning.
Major Acquisitions
BioTelemetry
- Year: 2021
- Acquisition Price (USD millions): 2800
- Strategic Rationale: To expand Philips' cardiac care portfolio and strengthen its position in remote patient monitoring.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends would be analyzed based on revenue, earnings, and market share.
Future Projections: Future growth projections would be based on analyst estimates and company guidance.
Recent Initiatives: Recent strategic initiatives would be highlighted, such as acquisitions, partnerships, and product launches.
Summary
Philips is a major healthcare technology company navigating a complex landscape. Its strengths lie in its brand, innovation, and global presence. However, quality control issues, restructuring costs, and intense competition pose challenges. Philips is positioned for growth in key healthcare segments but needs to address its weaknesses to maximize its potential.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
- Market research reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Koninklijke Philips NV ADR
Exchange NYSE | Headquaters - | ||
IPO Launch date 1987-12-30 | President, CEO & Chairman of the Board of Management Mr. Roy Jakobs | ||
Sector Healthcare | Industry Medical Devices | Full time employees 67247 | Website https://www.philips.com |
Full time employees 67247 | Website https://www.philips.com | ||
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.